tirzepatide hormones vs Semaglutide: What's the Difference? — Ryn Journal FDA Approves Tirzepatide, A Potential

Start your intake Why Insurance Companies Restrict GLP-1 Coverage for Weight Loss Most major insurers classify GLP-1 medications as weight loss drugs rather than metabolic disease treatments, creating a financial barrier for patients seeking appetite suppression therapy

To view or add a comment, sign in In light of the recent interest in dopamine agonists as a treatment of depression, I am curious whether this patient population as well is at risk for impulse control disorder Can dopaminergic medications affect impulse control

Together, they deliver better results than either treatment on its own

Another theory is that GLP-1s (glucagon-like peptide-1 receptor agonists) the class of medication semaglutide belongs to can cause nausea